What's Next In: Drug Delivery - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

What's Next In: Drug Delivery


Pharmaceutical Technology


5. S. Kommareddy, S.B. Tiwari, and M.M Amiji, "Long-Circulating Polymeric Nanovectors for tumor-selective Gene Delivery," Technol. Cancer Res. Treat. 4 (6), 615-625 (2005).

6. V.P. Torchilin. "Multifunctional Nanocarriers," Adv. Drug. Deliv. Rev. 58 (14), 1532-1555 (2006).

7. E. Wagner, "Programmed Drug Delivery: Nanosystems for Tumor Targeting," Expert Opin. Biol. Ther. 7 (5), 587-593 (2007).

8. V. Weissig and V.P. Torchilin. "Drug and DNA delivery to Mitochondria," Adv. Drug Deliv. Rev. 49 (1), 1-2 (2001).

9. A. K. Daly, "Individualized Drug Therapy," Curr. Opin. Drug Discov. Devel. 10 (1), 29-36 (2007).

10. J. Woodcock, "The Prospects for "Personalized Medicine" in Drug Development and Drug Therapy," Cli. Pharmaco.l Ther. 81, 164-169 (2007).

Industry experts give their predictions for the next 30 years. Read Editor-in-Chief Michelle Hoffman's introduction here. See what's next in:

Strategy and Regulation
Outsourcing
Solid-Dosage Formulation
Ingredients
Drug Delivery
Packaging
Analytical Testing
Information Technology


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here